EcoDrugPlus

Estrogen Receptor 2

Ensembl ID : ENSPEMG00000012465
Gene Symbol: ESR2
3 Cross references
273 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSPEMG00000024753
Gene Symbol: ESRRG
3 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPEMG00000010103
Gene Symbol: XPO1
3 Cross references
304 Possible Orthologues:

Expressed Sequence Ai182371

Ensembl ID : ENSPEMG00000023612
Gene Symbol: AI182371
1 Cross references
192 Possible Orthologues:

Farnesyl Diphosphate Farnesyl Transferase 1

Ensembl ID : ENSPEMG00000024279
Gene Symbol: FDFT1
1 Cross references
215 Possible Orthologues:

Farnesyl Diphosphate Synthetase

Ensembl ID : ENSPEMG00000030569
Gene Symbol: FDPS
1 Cross references
265 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSPEMG00000016669
Gene Symbol: FNTA
1 Cross references
221 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSPEMG00000008896
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSPEMG00000015175
Gene Symbol: FAP
3 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSPEMG00000016190
Gene Symbol: FGF2
3 Cross references
117 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSPEMG00000001204
Gene Symbol: FGFR1
3 Cross references
289 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSPEMG00000014436
Gene Symbol: FGFR2
3 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).